Route of Administration (Grade): Parenteral, Oral, Ophthalmic, Nasal, Topical, Oral and Inhalation.
Pharmacopoeia Reference: USP NF
Technical Specifications: Captisol® is a polyanionic beta-cyclodextrin derivative with a sodium sulfonate salt separated from the lipophilic cavity by a butyl ether spacer group, or sulfobutylether (SBE).
Pharmacopoeia Reference: In house having US DMF Type IV, IIG listed
Technical Specifications: Ready to use liquid polymer for topical applications (Gel / Cream / Lotion/ Foam based formulation, etc); It thickens over a wide range of pH 3-12; No HLB Calculation; No Neutralization